Findlay Park Partners LLP,
Artisan Partners Limited Partnership,
Westpac Banking Corp,
Skandinaviska Enskilda Banken AB publ,
Thrivent Financial for Lutherans, and
Strs Ohio have all reduced their stake in
Waters Corporation (WAT). Yet,
TD Asset Management Inc, Andra AP fonden, Intech Investment Management LLC, JPMorgan Chase & Co., Kovitz Investment Group Partners LLC, Alberta Investment Management Corp, Vanguard Group Inc., Rhumbline Advisers and Mawer Investment Management Ltd. have increased their holdings. The company's merger with
BD's Biosciences & Diagnostic Solutions Business has culminated, creating a life sciences and diagnostics leader focused on regulated, high-volume testing. This development could establish a strong support base for Waters' stock, although it brought some margin pressure offsetting revenue growth. Waters Corporation released its
Q4 2025 earnings report, meeting projections. However, the stock fell 14.5% due to
FY2026 guidance, even with a
Q4 beat. Wrath Corporation
CEO received new shares and RSUs as reward. The launch of
Next-Generation Biotherapeutics and
Higher Sensitivity LC Columns indicate a firm hold in innovation. Alberta Investment Management Corp takes a
$4.68 Million Positionin Waters Corporation. The current
average recommendation for Waters' stock from brokerages is a 'Moderate Buy'.
Waters Corp WAT News Analytics from Thu, 15 May 2025 07:00:00 GMT to Sat, 28 Feb 2026 12:35:06 GMT -
Rating 0
- Innovation 6
- Information 8
- Rumor -5
